Neonatal Onset Multisystem Inflammatory Disease Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub as a member
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Neonatal Onset Multisystem Inflammatory Disease
Neonatal Onset Multisystem Inflammatory Disease (NOMID) is a rare, severe genetic disorder causing widespread inflammation from infancy. While challenging, effective treatments exist, often at high costs. TheDrugClub helps families manage these expenses, ensuring access to vital medications through an affordable membership, making critical care more accessible.
Neonatal Onset Multisystem Inflammatory Disease (NOMID), also known as Chronic Infantile Neurological Cutaneous Articular (CINCA) syndrome, is the most severe form of Cryopyrin-Associated Periodic Syndromes (CAPS). This rare genetic disorder is caused by mutations in the NLRP3 gene, leading to an overproduction of the inflammatory protein interleukin-1 beta (IL-1β). Symptoms typically begin in infancy, manifesting as chronic fever, a characteristic skin rash, joint pain and swelling, and neurological problems including chronic aseptic meningitis, vision impairment, and hearing loss. If left untreated, NOMID can lead to severe organ damage, developmental delays, and significantly impact quality of life.
Managing NOMID primarily involves targeting the underlying inflammation. The most effective treatments are biologic medications that
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.